• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 444618 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416840352 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416840352 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Seattle Genetics Gives Way to the Analysts: Down 5.9% Since Last Week's Downgrade

Published on Wed, 02/20/2013 - 10:11
By Peter Chu

Seattle Genetics was downgraded from Buy to Hold by Needham one week ago. The stock closed at $27.70, which is 5.9% lower than the price one week ago ($29.44).

Seattle Genetics (NASDAQ:SGEN) is currently priced 14.7% above its average consensus analyst price target of $23.83. Seattle Genetics shares have support at the 50-day moving average (MA) of $26.91 and additional support at the 200-day MA of $25.32.

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

In the past 52 weeks, Seattle Genetics share prices have been bracketed by a low of $17.09 and a high of $30.85 and are now at $27.95, 64% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.3%.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Analyst Rating Flashback: Procter & Gamb...

A week ago, Canaccord Genuity downgraded Procter & Gamble from Buy to Hold. Procter & ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in Dillard's (NYSE:D ...

Hudson City Bancorp had the Lowest Relat...

Analysis was conducted on the Thrifts & Mortgage Finance industry to measure relative p ...

Short-term Underperformance Detected in ...

Here are 5 stocks in the Specialty Chemicals industry ranked by performance. We compil ...

Analysis of Relative Performance in the ...

Below are five companies in the Specialized Finance industry that underperformed yester ...

Shares of Intel Underperformed its Peers...

Here are 5 stocks in the Semiconductors industry ranked by performance. We compiled th ...

Shares of Ultratech Underperformed its P...

Analysis was conducted on the Semiconductor Equipment industry to measure relative perf ...

Shares of CBL & Associates Properties Un...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...